Sage Stock Sinks After FDA Decision on Depression Drug - Barron's

8/7/2023

Sage Stock Sinks After FDA Decision on Depression Drug  Barron'sFDA approves first postpartum depression pill from Biogen, Sage  Yahoo FinanceBiogen, Sage face challenges as FDA rejects pill for clinical depression  Yahoo NewsFirst FDA approved drug helping women through postpartum depression  WQAD News 8New mothers need all the help they can get  The Times...

Original

Categories: Financial | Stock

Tags: barron's | challenges | decision | depression | drug | face | fda | news | stock | times | women

---